Financial results - AMARIS PHARM SRL

Financial Summary - Amaris Pharm Srl
Unique identification code: 24738731
Registration number: J2008001951268
Nace: 4773
Sales - Ron
1.070.086
Net Profit - Ron
98.365
Employees
9
Open Account
Company Amaris Pharm Srl with Fiscal Code 24738731 recorded a turnover of 2024 of 1.070.086, with a net profit of 98.365 and having an average number of employees of 9. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Amaris Pharm Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 269.048 314.258 389.522 460.549 509.919 617.465 662.626 761.971 951.436 1.070.086
Total Income - EUR 269.457 314.633 389.555 460.643 509.958 617.481 666.773 762.073 951.669 1.069.662
Total Expenses - EUR 258.710 290.359 339.017 393.441 432.391 507.011 567.527 649.183 849.804 954.301
Gross Profit/Loss - EUR 10.748 24.273 50.538 67.202 77.566 110.470 99.246 112.890 101.864 115.361
Net Profit/Loss - EUR 8.781 20.444 46.231 62.576 73.154 107.001 93.988 106.758 91.495 98.365
Employees 6 7 7 7 8 8 8 8 9 9
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 13.1%, from 951.436 euro in the year 2023, to 1.070.086 euro in 2024. The Net Profit increased by 7.382 euro, from 91.495 euro in 2023, to 98.365 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Amaris Pharm Srl

Rating financiar

Financial Rating -
AMARIS PHARM SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Amaris Pharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Amaris Pharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Amaris Pharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Amaris Pharm Srl - CUI 24738731

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 4.203 3.076 2.864 2.606 1.647 11.592 24.644 25.631 41.258 34.193
Current Assets 87.511 108.552 149.783 174.880 195.945 227.877 210.324 239.458 324.118 355.336
Inventories 39.425 58.146 59.327 62.541 70.317 89.112 96.136 106.988 157.707 160.404
Receivables 14.915 7.526 25.024 42.271 32.901 39.340 43.426 52.736 77.683 86.946
Cash 33.171 42.881 65.431 70.069 92.727 99.426 70.762 79.734 88.728 107.986
Shareholders Funds 18.749 20.497 46.284 62.627 73.204 107.051 94.036 106.806 133.483 98.414
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 72.965 91.131 106.716 115.099 124.899 133.101 141.768 159.159 233.305 292.278
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 355.336 euro in 2024 which includes Inventories of 160.404 euro, Receivables of 86.946 euro and cash availability of 107.986 euro.
The company's Equity was valued at 98.414 euro, while total Liabilities amounted to 292.278 euro. Equity decreased by -34.323 euro, from 133.483 euro in 2023, to 98.414 in 2024.

Risk Reports Prices

Reviews - Amaris Pharm Srl

Comments - Amaris Pharm Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.